千日菊（ACMELLA OLERACEA）提取物 × 舒缓

大鼠在体实验显示局部应用20% Acmella oleracea软膏增加胶原含量和组织化，支持抗炎/舒缓功效。

In vivo rat experiment shows topical application of 20% Acmella oleracea ointment increases collagen content and organization, supporting anti-inflammatory/soothing efficacy.

小鼠在体实验显示含Acmella oleracea提取物的膜剂具有局部麻醉效果，支持舒缓功效。

In vivo mouse experiment shows film containing Acmella oleracea extract has local anesthetic effect, supporting soothing efficacy.

含Acmella oleracea提取物的血清显示皮肤保湿和微 relief 改善，但配方含多种成分，且与活性对照比较，无法单独归因。

Serum containing Acmella oleracea extract shows skin hydration and microrelief improvement, but formulation contains multiple ingredients and compared with active control, cannot be solely attributed.

配方含超分子视黄醇和Acmella oleracea提取物，显示改善黑眼圈和皱纹，但无法区分单一成分贡献。

Formulation contains supramolecular retinol and Acmella oleracea extract, shows improvement in dark circles and wrinkles, but cannot distinguish individual component contribution.

人体试验显示含Acmella oleracea提取物的乳液血清减少皱纹，但无对照组，且配方含多种成分，无法单独归因于该提取物。

Human trial shows emulsion serum containing Acmella oleracea extract reduces wrinkles, but no control group and formulation contains multiple ingredients, cannot be solely attributed to the extract.

组合物含Acmella oleracea提取物，体外显示神经放松活性，但未单独测试该提取物的舒缓功效。

Composition contains Acmella oleracea extract, in vitro shows neurorelaxant activity, but not tested alone for soothing efficacy.

仅评估了纳米制剂的物理稳定性和体外释放，未直接测试舒缓功效。

Only evaluated physical stability and in vitro release of nanoformulation, not directly tested soothing efficacy.

研究聚焦于抗肿瘤活性，未涉及舒缓功效。

Study focuses on antitumor activity, not soothing efficacy.